Evox Therapeutics
Engineering exosomes to deliver protein and nucleic acid-based therapeutics to treat life-threatening rare diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€332—498m (Dealroom.co estimates Feb 2021.)
Company register number 10076821
Oxford England (HQ)
Authorizing premium user...